Latest news with #PhilipMorrisInternational
Yahoo
3 days ago
- Business
- Yahoo
Philip Morris International (NYSE:PM) Reaffirms 2025 Earnings Forecast of US$7.01 to US$7.14
Philip Morris International recently confirmed its earnings forecast for 2025, maintaining a projected diluted EPS of $7.01 to $7.14. Over the past quarter, the company's shares showed an impressive increase of 19%. This movement could have been supported by the reaffirmation of strong earnings and favorable Q1 2025 results, which reported increased sales and net income compared to the previous year. Compared to the market's overall 12% rise over the past year, Philip Morris's stock performance underscores investor confidence, further consolidated by a regular quarterly dividend announcement. We've discovered 2 possible red flags for Philip Morris International that you should be aware of before investing here. The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. The recent reaffirmation of Philip Morris International's earnings forecast and strong short-term share price increase of 19% could bolster investor sentiment, further supporting the company's plans amidst potential volatility in U.S. markets. Over the past five years, Philip Morris's total shareholder return reached 205.61%, reflecting a solid growth trajectory that outpaced the previous years. In the past year, it has also outperformed the broader market's 12% rise, indicating a robust position in comparison to industry counterparts. The company's shares are currently trading below the consensus analyst price target of US$176.03, with a discount of 3.68%. This gap may suggest market skepticism or expected hurdles in maintaining revenue and margin projections, particularly in the face of challenges such as regulatory uncertainties and currency fluctuations. However, the solid performance of smoke-free product lines drives an optimistic outlook for future growth despite these risks. The revenue and earnings forecasts could be positively influenced if recent news reinforces consumer confidence and demand continues to strengthen, though it remains essential to assess these impacts alongside potential market constraints and regulatory developments. In light of our recent valuation report, it seems possible that Philip Morris International is trading beyond its estimated value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:PM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 days ago
- Business
- Business Wire
Philip Morris International Participates in dbAccess Global Consumer Conference
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2025 dbAccess Global Consumer Conference in Paris. The event will be webcast live in listen-only mode, beginning at approximately 11:15 a.m. CEST (5:15 a.m. EST), at and on the PMI Investor Relations Mobile Application ( An archived copy of the webcast will be available for approximately one year. 2025 Full-Year Forecast PMI reaffirms its 2025 full-year reported diluted EPS forecast, announced on April 23, 2025, of $7.01 to $7.14. Excluding a total 2025 adjustment of $0.35 per share and a favorable currency impact, at then-prevailing exchange rates, of $0.10 per share, this forecast represents a projected currency-neutral increase of 10.5% to 12.5% versus adjusted diluted EPS of $6.57 in 2024, as outlined in the below table. The assumptions underlying this forecast remain unchanged versus those communicated by PMI in its earnings release of April 23, 2025. Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates they were used by 38.6 million adults around the world. The smoke-free business accounted for 42% of PMI's first-quarter 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to 'PMI', 'we', 'our' and 'us' mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and Forward-Looking and Cautionary Statements This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; business plans and strategies; and dividends. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI. PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and/or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; recent and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance. PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2024, and the Quarterly Report on Form 10-Q for the first quarter ended March 31, 2025. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.
Yahoo
3 days ago
- Business
- Yahoo
Billionaire Stanley Druckenmiller Owns $175 Million of This Brilliant Dividend Growth Stock
Philip Morris International is one of the largest positions in Stan Druckenmiller's portfolio. The stock has soared because of its leading position in disruptive nicotine categories. The stock can produce plenty of dividend growth for the rest of this decade. 10 stocks we like better than Philip Morris International › It can pay to follow billionaire fund manager Stanley Druckenmiller, who has put up phenomenal market-beating returns for decades. One of the largest positions in his Duquesne Family Office is Philip Morris International (NYSE: PM). He owns $175 million worth of the stock, first purchased in the second quarter of 2024. Since then, shares have posted a total return of more than 100% as investors have gotten excited about the company's growth with new nicotine brands that are replacing cigarettes. Here's the brilliance behind Philip Morris' strategy, and why this is the perfect dividend growth stock over the next 10 years. Spun out as an independent company almost two decades ago, Philip Morris International is one of the leading tobacco companies that sells outside of the United States, while Altria Group sells its brands domestically. One benefit of owning Philip Morris International is the international diversification it can provide for your portfolio. Even though the company reports in U.S. dollars, the revenue it collects is generally outside the United States, which can help investors when the dollar is getting devalued versus foreign currencies, as is happening today. The stock has soared mainly because of the major investments the company made beyond cigarettes that are now bearing fruit. It has the leading nicotine pouch brand called Zyn, which is growing like wildfire in the United States, and with incredible profit margins. The brand has gone from virtually nothing 10 years ago to selling more than 200 million cans a quarter in the country. More globally, the Iqos heat-not-burn device brand is the leader in the category that is popular in Europe and Japan, driving tons of new revenue and earnings for Philip Morris International. Overall, 42% of the company's revenue now comes from its smoke-free business, driving overall revenue to $38.4 billion over the last 12 months. Dividends are the way that Philip Morris returns capital to shareholders. Its dividend yield is much lower than a year ago at 3%, but it still offers a solid yield for shareholders. One big factor in this dividend consistency is the steady cash flow produced by the legacy cigarette business. Usage for cigarettes is slowly declining in the markets in which it operates, but the company is in a much better position outside of the United States because of its exposure to countries with growing populations. It also has the leading brands that consumers of nicotine are switching to buy. Today, Philip Morris pays a dividend per share of $5.35. This will be funded by its free cash flow per share, currently at $6.55. No cash flow, no dividends. It's that simple at the end of the day. Free cash flow is actually depressed right now because of the large manufacturing build-out for nicotine pouches and heat-not-burn growth. Over the next five years, investors should see an inflection in free cash flow per share up to $10 or higher. In turn, this gives the company plenty of room to grow its dividend-per-share payout, which will boost the dividend yield as long as the stock price doesn't go up. Around 10% dividend growth for the next five years will put the stock's dividend-per-share payout at $8.61, which is well below what the company can generate in free cash flow. This gives the company an easy path to keep growing its dividend payout for shareholders. Even though the stock is up 100% in the last 12 months or so, Philip Morris International stock may still be a solid buy for investors today. Don't expect 100% returns every year, but the math works out that this stock is still cheaper than most you can buy today. It has a forward price-to-earnings ratio (P/E) of 24, which is not overly expensive for a consistent earnings grower. The dividend yield is well above the stock market average, with plenty of room to grow this yield in the years to come. Philip Morris has the dominant position in the growing trend of nicotine use without tobacco, which will make it a market share taker versus competitors. Put it together, and Philip Morris International is a great stock to buy and hold for the long haul. No wonder Druckenmiller has it as one of the largest positions in his portfolio. Before you buy stock in Philip Morris International, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Philip Morris International wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Brett Schafer has no position in any of the stocks mentioned. The Motley Fool recommends Philip Morris International. The Motley Fool has a disclosure policy. Billionaire Stanley Druckenmiller Owns $175 Million of This Brilliant Dividend Growth Stock was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-05-2025
- Business
- Yahoo
Philip Morris International to Host Webcast of Presentation at the 2025 dbAccess Global Consumer Conference
STAMFORD, CT, May 27, 2025--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of the company's remarks and Q&A session with Emmanuel Babeau, Chief Financial Officer, at the 2025 dbAccess Global Consumer Conference on Tuesday, June 3, 2025, at approximately 11:15 a.m. CET (5:15 a.m. ET). The Webcast and presentation slides will be available at with a post-event recording of the webcast available for one year at the same site. The webcast will provide a live stream of the entire PMI session and can also be accessed on mobile devices by downloading PMI's free Investor Relations Mobile App at Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates they were used by 38.6 million adults around the world. The smoke-free business accounted for 42% of PMI's first-quarter 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to "PMI", "we", "our" and "us" mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and View source version on Contacts Philip Morris International Investor Relations:Stamford, CT: +1 (203) 904 2410Lausanne: +41 (0)58 242 4666Email: InvestorRelations@ Media: David FraserLausanne: +41 (0)58 242 4500Email: Sign in to access your portfolio
Business Wire
27-05-2025
- Business
- Business Wire
Philip Morris International to Host Webcast of Presentation at the 2025 dbAccess Global Consumer Conference
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of the company's remarks and Q&A session with Emmanuel Babeau, Chief Financial Officer, at the 2025 dbAccess Global Consumer Conference on Tuesday, June 3, 2025, at approximately 11:15 a.m. CET (5:15 a.m. ET). The Webcast and presentation slides will be available at with a post-event recording of the webcast available for one year at the same site. The webcast will provide a live stream of the entire PMI session and can also be accessed on mobile devices by downloading PMI's free Investor Relations Mobile App at Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates they were used by 38.6 million adults around the world. The smoke-free business accounted for 42% of PMI's first-quarter 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to 'PMI', 'we', 'our' and 'us' mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and
